Benchling
Benchling's mission is to accelerate life sciences R&D by providing a unified cloud platform that centralizes scientific data, collaboration, and workflows.
At a Glance
- Biopharma
- AgTech
- Industrial Biotech
- Academic Institutions
AI Tools by Benchling
(1)
Benchling
Life Sciences R&D Platform
Discussions
No discussions yet
Be the first to start a discussion about Benchling
Latest News
Benchling announces major AI releases at Benchtalk 2025
Benchling launches industry-first solution for RNA Therapeutics
Benchling kicks off Benchtalk 2024 with highlights on AI-native science
Benchling introduces AlphaFold integration and Benchling Connect
Products & Services
A cloud-based Electronic Lab Notebook (ELN) for documentation and collaboration.
Tools for DNA design, CRISPR guide design, and sequence analysis.
A central repository for tracking biological entities and their relationships.
Sample management system for tracking containers, plates, and storage.
Market Position
Benchling positions itself as the only biology-first 'R&D Cloud' that replaces fragmented, legacy point solutions with a modern, unified platform for end-to-end data traceability and collaboration.
Leadership
Founders
Sajith Wickramasekara
Co-founder and CEO. Previously a Research Assistant at Liquidia Technologies and Duke University Medical Center. Studied Computer Science at MIT, left at 22 to start Benchling. Forbes 30 Under 30.
Ashu Singhal
Co-founder and President. Previously a Software Engineer at Twitter. Studied Computer Science at MIT.
Executive Team
Sajith Wickramasekara
CEO and Co-founder
Leader of company strategy; MIT CS background.
Ashu Singhal
President and Co-founder
Focus on product and engineering leadership; former Twitter engineer.
Board of Directors
Founding Story
Sajith Wickramasekara and Ashu Singhal founded Benchling in 2012 while at MIT. They observed that scientists were burdened by paper notebooks and legacy software that couldn't handle the complexity of modern biology, and aimed to create a 'Google Docs for biology' to modernize research.
Business Model
Revenue Model
B2B SaaS subscription model with tiered pricing based on user count and features.
Pricing Tiers
Available for individual academic researchers and students.
Designed for small biotech teams; typically includes ~5 seats and basic support.
Full-featured platform scaled for large organizations with advanced security and support.
Target Markets
- Biopharma
- AgTech
- Industrial Biotech
- Academic Institutions
- Biopharmaceutical discovery and development
- Agricultural biotechnology
- Industrial biotechnology and synthetic biology
- Academic research
- Gene and cell therapy development
- RNA therapeutic design
- Regeneron
- Gilead Sciences
- Sanofi
- Biogen